Presynaptic control of serotonin on striatal dopamine function.
Identifieur interne : 001619 ( Main/Merge ); précédent : 001618; suivant : 001620Presynaptic control of serotonin on striatal dopamine function.
Auteurs : Sylvia Navailles [France] ; Philippe De DeurwaerdèreSource :
- Psychopharmacology [ 1432-2072 ] ; 2011.
English descriptors
- KwdEn :
- Animals, Corpus Striatum (metabolism), Dopamine (metabolism), Humans, Neurons (metabolism), Parkinson Disease (physiopathology), Presynaptic Terminals (metabolism), Receptors, Serotonin (metabolism), Schizophrenia (physiopathology), Serotonin (metabolism), Serotonin Antagonists (pharmacology), Serotonin Receptor Agonists (pharmacology).
- MESH :
- chemical , metabolism : Dopamine, Receptors, Serotonin, Serotonin.
- metabolism : Corpus Striatum, Neurons, Presynaptic Terminals.
- chemical , pharmacology : Serotonin Antagonists, Serotonin Receptor Agonists.
- physiopathology : Parkinson Disease, Schizophrenia.
- Animals, Humans.
Abstract
The influences of the serotonergic system on dopamine (DA) neuron activity have received considerable attention during the last three decades due to the real opportunity to improve disorders related to central DA neuron dysfunctions such as Parkinson's disease, schizophrenia, or drug abuse with serotonergic drugs. Numerous biochemical and behavioral data indicate that serotonin (5-HT) affects dopaminergic terminal function in the striatum.
Url:
DOI: 10.1007/s00213-010-2029-y
PubMed: 20953589
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000A06
- to stream PubMed, to step Curation: 000966
- to stream PubMed, to step Checkpoint: 000966
- to stream Ncbi, to step Merge: 000C36
- to stream Ncbi, to step Curation: 000C36
- to stream Ncbi, to step Checkpoint: 000C36
- to stream Hal, to step Corpus: 000912
- to stream Hal, to step Curation: 000912
- to stream Hal, to step Checkpoint: 000596
Links to Exploration step
pubmed:20953589Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Presynaptic control of serotonin on striatal dopamine function.</title><author><name sortKey="Navailles, Sylvia" sort="Navailles, Sylvia" uniqKey="Navailles S" first="Sylvia" last="Navailles">Sylvia Navailles</name><affiliation wicri:level="3"><nlm:affiliation>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="De Deurwaerdere, Philippe" sort="De Deurwaerdere, Philippe" uniqKey="De Deurwaerdere P" first="Philippe" last="De Deurwaerdère">Philippe De Deurwaerdère</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:20953589</idno><idno type="pmid">20953589</idno><idno type="doi">10.1007/s00213-010-2029-y</idno><idno type="wicri:Area/PubMed/Corpus">000A06</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A06</idno><idno type="wicri:Area/PubMed/Curation">000966</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000966</idno><idno type="wicri:Area/PubMed/Checkpoint">000966</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000966</idno><idno type="wicri:Area/Ncbi/Merge">000C36</idno><idno type="wicri:Area/Ncbi/Curation">000C36</idno><idno type="wicri:Area/Ncbi/Checkpoint">000C36</idno><idno type="wicri:source">HAL</idno><idno type="RBID">Hal:hal-01178533</idno><idno type="url">https://hal.archives-ouvertes.fr/hal-01178533</idno><idno type="wicri:Area/Hal/Corpus">000912</idno><idno type="wicri:Area/Hal/Curation">000912</idno><idno type="wicri:Area/Hal/Checkpoint">000596</idno><idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000596</idno><idno type="wicri:doubleKey">0033-3158:2011:Navailles S:presynaptic:control:of</idno><idno type="wicri:Area/Main/Merge">001619</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Presynaptic control of serotonin on striatal dopamine function.</title><author><name sortKey="Navailles, Sylvia" sort="Navailles, Sylvia" uniqKey="Navailles S" first="Sylvia" last="Navailles">Sylvia Navailles</name><affiliation wicri:level="3"><nlm:affiliation>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="De Deurwaerdere, Philippe" sort="De Deurwaerdere, Philippe" uniqKey="De Deurwaerdere P" first="Philippe" last="De Deurwaerdère">Philippe De Deurwaerdère</name></author></analytic><series><title level="j">Psychopharmacology</title><idno type="eISSN">1432-2072</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Corpus Striatum (metabolism)</term><term>Dopamine (metabolism)</term><term>Humans</term><term>Neurons (metabolism)</term><term>Parkinson Disease (physiopathology)</term><term>Presynaptic Terminals (metabolism)</term><term>Receptors, Serotonin (metabolism)</term><term>Schizophrenia (physiopathology)</term><term>Serotonin (metabolism)</term><term>Serotonin Antagonists (pharmacology)</term><term>Serotonin Receptor Agonists (pharmacology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term><term>Receptors, Serotonin</term><term>Serotonin</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Corpus Striatum</term><term>Neurons</term><term>Presynaptic Terminals</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Serotonin Antagonists</term><term>Serotonin Receptor Agonists</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term><term>Schizophrenia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The influences of the serotonergic system on dopamine (DA) neuron activity have received considerable attention during the last three decades due to the real opportunity to improve disorders related to central DA neuron dysfunctions such as Parkinson's disease, schizophrenia, or drug abuse with serotonergic drugs. Numerous biochemical and behavioral data indicate that serotonin (5-HT) affects dopaminergic terminal function in the striatum.</div></front></TEI><double doi="10.1007/s00213-010-2029-y"><HAL><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Presynaptic control of serotonin on striatal dopamine function.</title><author><name sortKey="Navailles, Sylvia" sort="Navailles, Sylvia" uniqKey="Navailles S" first="Sylvia" last="Navailles">Sylvia Navailles</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID"> <orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName> <orgName type="acronym">IMN</orgName> <desc> <address> <addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine> <country key="FR"></country> </address> <ref type="url">http://imn-bordeaux.org/</ref> </desc> <listRelation> <relation active="#struct-259761" type="direct"></relation> <relation name="UMR5293" active="#struct-441569" type="direct"></relation> </listRelation><tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID"> <orgName>Université de Bordeaux</orgName> <orgName type="acronym">UB</orgName> <desc> <address> <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine> <country key="FR"></country> </address> <ref type="url">http://www.u-bordeaux.fr/</ref> </desc></org></tutelle><tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno> <idno type="ISNI">0000000122597504</idno> <orgName>Centre National de la Recherche Scientifique</orgName> <orgName type="acronym">CNRS</orgName> <date type="start">1939-10-19</date> <desc> <address> <country key="FR"></country> </address> <ref type="url">http://www.cnrs.fr/</ref> </desc></org></tutelle></tutelles></hal:affiliation><country>France</country><placeName><settlement type="city">Bordeaux</settlement><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region></placeName><orgName type="university">Université de Bordeaux</orgName></affiliation></author><author><name sortKey="De Deurwaerdere, Philippe" sort="De Deurwaerdere, Philippe" uniqKey="De Deurwaerdere P" first="Philippe" last="De Deurwaerdère">Philippe De Deurwaerdère</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID"> <orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName> <orgName type="acronym">IMN</orgName> <desc> <address> <addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine> <country key="FR"></country> </address> <ref type="url">http://imn-bordeaux.org/</ref> </desc> <listRelation> <relation active="#struct-259761" type="direct"></relation> <relation name="UMR5293" active="#struct-441569" type="direct"></relation> </listRelation><tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID"> <orgName>Université de Bordeaux</orgName> <orgName type="acronym">UB</orgName> <desc> <address> <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine> <country key="FR"></country> </address> <ref type="url">http://www.u-bordeaux.fr/</ref> </desc></org></tutelle><tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno> <idno type="ISNI">0000000122597504</idno> <orgName>Centre National de la Recherche Scientifique</orgName> <orgName type="acronym">CNRS</orgName> <date type="start">1939-10-19</date> <desc> <address> <country key="FR"></country> </address> <ref type="url">http://www.cnrs.fr/</ref> </desc></org></tutelle></tutelles></hal:affiliation><country>France</country><placeName><settlement type="city">Bordeaux</settlement><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region></placeName><orgName type="university">Université de Bordeaux</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">HAL</idno><idno type="RBID">Hal:hal-01178533</idno><idno type="halId">hal-01178533</idno><idno type="halUri">https://hal.archives-ouvertes.fr/hal-01178533</idno><idno type="url">https://hal.archives-ouvertes.fr/hal-01178533</idno><idno type="doi">10.1007/s00213-010-2029-y</idno><date when="2011-01-31">2011-01-31</date><idno type="wicri:Area/Hal/Corpus">000912</idno><idno type="wicri:Area/Hal/Curation">000912</idno><idno type="wicri:Area/Hal/Checkpoint">000596</idno><idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000596</idno><idno type="wicri:doubleKey">0033-3158:2011:Navailles S:presynaptic:control:of</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Presynaptic control of serotonin on striatal dopamine function.</title><author><name sortKey="Navailles, Sylvia" sort="Navailles, Sylvia" uniqKey="Navailles S" first="Sylvia" last="Navailles">Sylvia Navailles</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID"> <orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName> <orgName type="acronym">IMN</orgName> <desc> <address> <addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine> <country key="FR"></country> </address> <ref type="url">http://imn-bordeaux.org/</ref> </desc> <listRelation> <relation active="#struct-259761" type="direct"></relation> <relation name="UMR5293" active="#struct-441569" type="direct"></relation> </listRelation><tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID"> <orgName>Université de Bordeaux</orgName> <orgName type="acronym">UB</orgName> <desc> <address> <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine> <country key="FR"></country> </address> <ref type="url">http://www.u-bordeaux.fr/</ref> </desc></org></tutelle><tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno> <idno type="ISNI">0000000122597504</idno> <orgName>Centre National de la Recherche Scientifique</orgName> <orgName type="acronym">CNRS</orgName> <date type="start">1939-10-19</date> <desc> <address> <country key="FR"></country> </address> <ref type="url">http://www.cnrs.fr/</ref> </desc></org></tutelle></tutelles></hal:affiliation><country>France</country><placeName><settlement type="city">Bordeaux</settlement><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region></placeName><orgName type="university">Université de Bordeaux</orgName></affiliation></author><author><name sortKey="De Deurwaerdere, Philippe" sort="De Deurwaerdere, Philippe" uniqKey="De Deurwaerdere P" first="Philippe" last="De Deurwaerdère">Philippe De Deurwaerdère</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID"> <orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName> <orgName type="acronym">IMN</orgName> <desc> <address> <addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine> <country key="FR"></country> </address> <ref type="url">http://imn-bordeaux.org/</ref> </desc> <listRelation> <relation active="#struct-259761" type="direct"></relation> <relation name="UMR5293" active="#struct-441569" type="direct"></relation> </listRelation><tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID"> <orgName>Université de Bordeaux</orgName> <orgName type="acronym">UB</orgName> <desc> <address> <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine> <country key="FR"></country> </address> <ref type="url">http://www.u-bordeaux.fr/</ref> </desc></org></tutelle><tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno> <idno type="ISNI">0000000122597504</idno> <orgName>Centre National de la Recherche Scientifique</orgName> <orgName type="acronym">CNRS</orgName> <date type="start">1939-10-19</date> <desc> <address> <country key="FR"></country> </address> <ref type="url">http://www.cnrs.fr/</ref> </desc></org></tutelle></tutelles></hal:affiliation><country>France</country><placeName><settlement type="city">Bordeaux</settlement><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region></placeName><orgName type="university">Université de Bordeaux</orgName></affiliation></author></analytic><idno type="DOI">10.1007/s00213-010-2029-y</idno><series><title level="j">Psychopharmacology</title><idno type="ISSN">0033-3158</idno><imprint><date type="datePub">2011-01-31</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The influences of the serotonergic system on dopamine (DA) neuron activity have received considerable attention during the last three decades due to the real opportunity to improve disorders related to central DA neuron dysfunctions such as Parkinson's disease, schizophrenia, or drug abuse with serotonergic drugs. Numerous biochemical and behavioral data indicate that serotonin (5-HT) affects dopaminergic terminal function in the striatum. The authors propose a thorough examination of data showing controversial effects induced by striatal 5-HT on dopaminergic activity. Inhibitory and excitatory effects of exogenous 5-HT have been reported on DA release and synthesis, involving various striatal 5-HT receptors. 5-HT also promotes an efflux of DA through reversal of the direction of DA transport. By analogy with the mechanism of action described for amphetamine, the consequences of 5-HT entering DA terminals might explain both the excitatory and inhibitory effects of 5-HT on presynaptic DA terminal activity, but the physiological relevance of this mechanism is far from clear. The recent data suggest that the endogenous 5-HT system affects striatal DA release in a state-dependent manner associated with the conditional involvement of various 5-HT receptors such as 5-HT(2A), 5-HT(2C), 5-HT(3), and 5-HT(4) receptors. Methodological and pharmacological issues have prevented a comprehensive overview of the influence of 5-HT on striatal DA activity. The distribution of striatal 5-HT receptors and their restricted influence on DA neuron activity suggest that the endogenous 5-HT system exerts multiple and subtle influences on DA-mediated behaviors.</div></front></TEI></HAL><PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Presynaptic control of serotonin on striatal dopamine function.</title><author><name sortKey="Navailles, Sylvia" sort="Navailles, Sylvia" uniqKey="Navailles S" first="Sylvia" last="Navailles">Sylvia Navailles</name><affiliation wicri:level="3"><nlm:affiliation>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="De Deurwaerdere, Philippe" sort="De Deurwaerdere, Philippe" uniqKey="De Deurwaerdere P" first="Philippe" last="De Deurwaerdère">Philippe De Deurwaerdère</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:20953589</idno><idno type="pmid">20953589</idno><idno type="doi">10.1007/s00213-010-2029-y</idno><idno type="wicri:Area/PubMed/Corpus">000A06</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A06</idno><idno type="wicri:Area/PubMed/Curation">000966</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000966</idno><idno type="wicri:Area/PubMed/Checkpoint">000966</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000966</idno><idno type="wicri:Area/Ncbi/Merge">000C36</idno><idno type="wicri:Area/Ncbi/Curation">000C36</idno><idno type="wicri:Area/Ncbi/Checkpoint">000C36</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Presynaptic control of serotonin on striatal dopamine function.</title><author><name sortKey="Navailles, Sylvia" sort="Navailles, Sylvia" uniqKey="Navailles S" first="Sylvia" last="Navailles">Sylvia Navailles</name><affiliation wicri:level="3"><nlm:affiliation>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5227, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="De Deurwaerdere, Philippe" sort="De Deurwaerdere, Philippe" uniqKey="De Deurwaerdere P" first="Philippe" last="De Deurwaerdère">Philippe De Deurwaerdère</name></author></analytic><series><title level="j">Psychopharmacology</title><idno type="eISSN">1432-2072</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Corpus Striatum (metabolism)</term><term>Dopamine (metabolism)</term><term>Humans</term><term>Neurons (metabolism)</term><term>Parkinson Disease (physiopathology)</term><term>Presynaptic Terminals (metabolism)</term><term>Receptors, Serotonin (metabolism)</term><term>Schizophrenia (physiopathology)</term><term>Serotonin (metabolism)</term><term>Serotonin Antagonists (pharmacology)</term><term>Serotonin Receptor Agonists (pharmacology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term><term>Receptors, Serotonin</term><term>Serotonin</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Corpus Striatum</term><term>Neurons</term><term>Presynaptic Terminals</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Serotonin Antagonists</term><term>Serotonin Receptor Agonists</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term><term>Schizophrenia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The influences of the serotonergic system on dopamine (DA) neuron activity have received considerable attention during the last three decades due to the real opportunity to improve disorders related to central DA neuron dysfunctions such as Parkinson's disease, schizophrenia, or drug abuse with serotonergic drugs. Numerous biochemical and behavioral data indicate that serotonin (5-HT) affects dopaminergic terminal function in the striatum.</div></front></TEI></PubMed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001619 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001619 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:20953589
|texte= Presynaptic control of serotonin on striatal dopamine function.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:20953589" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |